Skip to main content
. 2024 May 15;25(10):5385. doi: 10.3390/ijms25105385

Table 4.

Patient CYP2C19 phenotype in the represented samples.

CYP2C19 Metabolizer Status n (%) LDL-C at Hospitalization (mmol/L) Median (Min-Max) LDL-C
6 Months after Hospitalization (mmol/L) Median (Min-Max)
∆LDL-C (mmol/L) Median (Min-Max) p-Value ***
Normal metabolizer 66 (71) 3.88 (2.87–6.36) 2.24 (1.17–5.41) ** 1.69 (0.13–3.57) 0.006
Poor metabolizer * 27 (29) 3.78 (2.79–6.32) 2.78 (1.19–5.97) ** 0.49 (0.01–4.09)
Total 93 (100) 3.87 (2.79–6.36) 2.29 (1.17–5.97)

* CYP2C19 *2, *4, *8; ** the LDL-C values between two medians differed, p = 0.01; *** p-value between medians of ∆LDL-C.